Jennifer Sees
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jennifer Sees has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
Bronwen E. Shaw
Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin
2 shared publicationsL. Hall
2 shared publicationsMichael A. Pulsipher
Division of Hematology, Oncology, and Blood and Marrow Transplantation, Children's Hospital Los Angeles, USC Keck School of Medicine, Los Angeles, California
2 shared publicationsAmelia Bystry
Division of Hematology and Oncology, Department of Pediatrics, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, USA
1 shared publicationAmir Steinberg
Mount Sinai Medical Center, New York, New York
1 shared publication- Anna M. DeSalvo
CIBMTR® (Center for International Blood and Marrow Transplant Research) NMDP, Minneapolis, MN
1 shared publication
Latest Publications
- Open Access
- 21 June 2024
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 30 (9) , 864-875
Applying Implementation Science in the Field of Transplant and Cellular Therapy
- 21 June 2024
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 30 (9) , 864-875
Open AccessApplying Implementation Science in the Field of Transplant and Cellular Therapy
- Open Access
- 20 February 2020
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 26 (6) , 1210-1217
Collection of Peripheral Blood Progenitor Cells in 1 Day Is Associated with Decreased Donor Toxicity Compared to 2 Days in Unrelated Donors
- 20 February 2020
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 26 (6) , 1210-1217
Open AccessCollection of Peripheral Blood Progenitor Cells in 1 Day Is Associated with Decreased Donor Toxicity Compared to 2 Days in Unrelated Donors
- 15 January 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 12 (526)
Engraftment of rare, pathogenic donor hematopoietic mutations in unrelated hematopoietic stem cell transplantation
Donor hematopoietic clones with pathogenic mutations engraft and persist in unrelated hematopoietic stem cell transplant recipients.
- 15 January 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 12 (526)
Engraftment of rare, pathogenic donor hematopoietic mutations in unrelated hematopoietic stem cell transplantation
Donor hematopoietic clones with pathogenic mutations engraft and persist in unrelated hematopoietic stem cell transplant recipients.
- 1 November 1998
- Published by Trans Tech Publications, Ltd. in Solid State Phenomena
- Vol. 65-66, 53-58
Chemistry of the Silicon Oxide Surface: Adsorption from SC1 Solutions
- 1 November 1998
- Published by Trans Tech Publications, Ltd. in Solid State Phenomena
- Vol. 65-66, 53-58
Chemistry of the Silicon Oxide Surface: Adsorption from SC1 Solutions
- 1 September 1998
- Published by Springer Nature in Journal of Materials Research
- Vol. 13 (9) , 2643-2648
Investigation of CF3I as an Environmentally Benign Dielectric Etchant
In this study, trifluoroiodomethane (CF3I), a non-global-warming gas, has been investigated as a substitute for typical PFC's currently used in wafer patterning and CVD chamber cleaning processes. Dielectric films consisting of plasma enhanced chemically vapor deposited silicon dioxide and silicon nitride were comparatively etched in CF3I and C2F6/O2 plasma environments. The etch rate of these films was ascertained as a function of applied rf power, etchant gas flow rate, reaction chamber pressure, and CF3I: O2 ratio. Destruction efficiencies of CF3I at different processing parameters were evaluated. Depending on the flow rate, rf power, and chamber pressure, utilization efficiency of CF3I varied from as low as 10% to as high as 68%. CF4, C2F6, COF2, and CO2 were the predominant by-products found in the exhaust stream; however, their concentrations were very low compared to the traditional process employing C2F6/O2 mixtures.
- 1 September 1998
- Published by Springer Nature in Journal of Materials Research
- Vol. 13 (9) , 2643-2648
Investigation of CF3I as an Environmentally Benign Dielectric Etchant
In this study, trifluoroiodomethane (CF3I), a non-global-warming gas, has been investigated as a substitute for typical PFC's currently used in wafer patterning and CVD chamber cleaning processes. Dielectric films consisting of plasma enhanced chemically vapor deposited silicon dioxide and silicon nitride were comparatively etched in CF3I and C2F6/O2 plasma environments. The etch rate of these films was ascertained as a function of applied rf power, etchant gas flow rate, reaction chamber pressure, and CF3I: O2 ratio. Destruction efficiencies of CF3I at different processing parameters were evaluated. Depending on the flow rate, rf power, and chamber pressure, utilization efficiency of CF3I varied from as low as 10% to as high as 68%. CF4, C2F6, COF2, and CO2 were the predominant by-products found in the exhaust stream; however, their concentrations were very low compared to the traditional process employing C2F6/O2 mixtures.